Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
PS01 - Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 09:00
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PS01.01 - Welcome Video
07:00 - 07:02
- Abstract
No abstract available for this presentation
-
+
PS01.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study
07:02 - 07:12 | Presenter: Pan-Chyr Yang
- Abstract
Loading... -
+
PS01.03 - Discussant
07:12 - 07:20 | Presenter: Ugo Pastorino
- Abstract
No abstract available for this presentation
-
+
PS01.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
07:20 - 07:30 | Presenter: Silvia Novello
- Abstract
Loading... -
+
PS01.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
07:30 - 07:40 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
PS01.06 - Discussant
07:40 - 07:50 | Presenter: Shinichi Toyooka
- Abstract
No abstract available for this presentation
-
+
PS01.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer
07:50 - 08:00 | Presenter: Bob T. Li
- Abstract
Loading... -
+
PS01.08 - Discussant
08:00 - 08:08 | Presenter: Pasi Antero Jänne
- Abstract
No abstract available for this presentation
-
+
PS01.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598
08:08 - 08:18 | Presenter: Michael Boyer
- Abstract
Loading... -
+
PS01.10 - Discussant
08:18 - 08:26 | Presenter: Yun Fan
- Abstract
No abstract available for this presentation
-
+
PS01.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
08:26 - 08:36 | Presenter: Dean Fennell
- Abstract
Loading... -
+
PS01.12 - Discussant
08:36 - 08:44 | Presenter: Rina Hui
- Abstract
No abstract available for this presentation
-
+
PS01.13 - Live Q&A
08:44 - 09:00
- Abstract
No abstract available for this presentation
-
+
PS01.14 - Chair
07:00 - 07:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
ES09 - Biomarkers in Immunotherapy
- 09:15 - 10:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
ES09.01 - Chair
09:15 - 09:15 | Presenter: Katerina Politi
- Abstract
No abstract available for this presentation
-
+
ES09.02 - Chair
09:15 - 09:15 | Presenter: Melina Elpi Marmarelis
- Abstract
No abstract available for this presentation
-
+
ES09.03 - Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
09:15 - 09:25 | Presenter: Solange Peters
- Abstract
Loading... -
+
ES09.04 - Individual Genomic Alterations as Predictive Factors for NSCLC Immunotherapy
09:25 - 09:35 | Presenter: Ferdinandos Skoulidis
- Abstract
No abstract available for this presentation
-
+
ES09.05 - Blood-based Biomarkers for Immunotherapy: Applications and Limitations
09:35 - 09:45 | Presenter: Lizza Hendriks
- Abstract
Loading... -
+
ES09.06 - Immune Contexture and Immunotherapy Response in NSCLC
09:45 - 09:55 | Presenter: Kurt Alex Schalper
- Abstract
No abstract available for this presentation
-
+
ES09.07 - Immunotherapy Biomarkers in NSCLC: Looking into the Future
09:55 - 10:05 | Presenter: Vamsidhar Velcheti
- Abstract
No abstract available for this presentation
-
+
ES09.08 - Live Q&A
10:05 - 10:15
- Abstract
No abstract available for this presentation
-
+
ES10 - Advances in Lung Cancer Screening Through Imaging and Data Analytics
- 09:15 - 10:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Screening and Early Detection
-
+
ES10.01 - Chair
09:15 - 09:15 | Presenter: Charlene J Liew
- Abstract
No abstract available for this presentation
-
+
ES10.02 - Chair
09:15 - 09:15 | Presenter: Yeol Kim
- Abstract
No abstract available for this presentation
-
+
ES10.03 - AI-Enabled Lung Cancer Predictive Analytics - The Future of Lung Cancer Screening?
09:15 - 09:27 | Presenter: Zaiyi Liu
- Abstract
No abstract available for this presentation
-
+
ES10.05 - Size Isn't Everything - Other High-Risk CT Imaging Features
09:27 - 09:39 | Presenter: Heber MacMahon
- Abstract
No abstract available for this presentation
-
+
ES10.06 - Putting It Together: Current Best Practices in the Evaluation and Follow-Up of the Indeterminate Pulmonary Nodule
09:39 - 09:51 | Presenter: David Raymond Baldwin
- Abstract
Loading... -
+
ES10.07 - Live Q&A
09:51 - 10:15
- Abstract
No abstract available for this presentation
-
+
ES11 - Practice Changing Initiatives
- 09:15 - 10:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Nursing and Allied Health Professionals
-
+
ES11.01 - Chair
09:15 - 09:15 | Presenter: Maria Ftanou
- Abstract
No abstract available for this presentation
-
+
ES11.02 - Chair
09:15 - 09:15 | Presenter: Anne Fraser
- Abstract
No abstract available for this presentation
-
+
ES11.03 - Managing the Psychological Needs of Patients in a Screening Service
09:15 - 09:27 | Presenter: Lisa Burgess
- Abstract
Loading... -
+
ES11.04 - Assessment of Physical Function in Patients Undergoing Lung-sparing Surgery for Malignant Pleural Mesothelioma
09:27 - 09:39 | Presenter: Simon Ho
- Abstract
Loading... -
+
ES11.05 - Effect of Qigong on Symptom Management of Lung Cancer Patients
09:39 - 09:51 | Presenter: Shirley Siu-yin Ching
- Abstract
No abstract available for this presentation
-
+
ES11.06 - Developing a Care Board
09:51 - 10:03 | Presenter: Manuela Eicher
- Abstract
Loading... -
+
ES11.07 - Preoperative Exercise Training for Patients with Non-Small Cell Lung Cancer
10:03 - 10:18 | Presenter: Catherine Granger
- Abstract
No abstract available for this presentation
-
+
ES11.08 - Live Q&A
10:18 - 10:43
- Abstract
No abstract available for this presentation
-
+
ES12 - Public Health Issues in Lung Cancer Screening
- 10:30 - 11:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Screening and Early Detection
-
+
ES12.01 - Patient Perspective on Lung Cancer Screening and Health Disparities
10:30 - 10:45 | Presenter: Andrea Borondy-Kitts
- Abstract
Loading... -
+
ES12.02 - Defining High Risk
10:45 - 11:00 | Presenter: Martin Carl Tammemagi
- Abstract
Loading... -
+
ES12.03 - Screening in Indigenous Maori Population
11:00 - 11:15 | Presenter: Sue Crengle
- Abstract
No abstract available for this presentation
-
+
ES12.04 - Mobile CT and Effective Screening for Underserved Populations
11:15 - 11:30 | Presenter: Carlijn van der Aalst
- Abstract
No abstract available for this presentation
-
+
OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed
- 10:30 - 11:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
OA07.01 - Chair
10:30 - 10:30 | Presenter: Jyoti D Patel
- Abstract
No abstract available for this presentation
-
+
OA07.02 - Chair
10:30 - 10:30 | Presenter: Aaron Lisberg
- Abstract
No abstract available for this presentation
-
+
OA07.03 - Comutations in DDR Pathways Predict Atezolizumab Response in Non-Small Cell Lung Cancer Patients
10:30 - 10:40 | Presenter: Wei Nie
- Abstract
Loading... -
+
OA07.04 - LKB1 Deficiency Leads to an “Adenosine-Rich” Tumor Microenvironment by Recruiting Myeloid-Derived Suppressive Cells
10:40 - 10:50 | Presenter: Xue Bai
- Abstract
Loading... -
+
OA07.05 - Discussant
10:50 - 10:55 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
OA07.06 - Interdependence of KRAS and TP53 Mutations in Predicting ICI Efficacy in EGFR/ALKWT Non-Squamous NSCLC: Results From 1129 Patient-Level Data
10:55 - 11:00 | Presenter: Lin Li
- Abstract
Loading... -
+
OA07.07 - PARP1 Inhibitors Enhanced IFNγ-Induced PD-L1 Expression in LKB1-Mutant Lung Cancer
11:00 - 11:05 | Presenter: Xue Bai
- Abstract
Loading... -
+
OA07.08 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy
11:05 - 11:10 | Presenter: Benjamin Besse
- Abstract
Loading... -
+
OA07.09 - Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints
11:10 - 11:15 | Presenter: Baohui Han
- Abstract
Loading... -
+
OA07.10 - Discussant
11:15 - 11:20 | Presenter: Laura Mezquita
- Abstract
No abstract available for this presentation
-
+
OA07.11 - Live Q&A
11:20 - 11:30
- Abstract
No abstract available for this presentation
-
+
ES14 - Novel Immunotherapy Strategies in NSCLC
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
ES14.02 - Cellular Therapies in NSCLC
11:45 - 11:57 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC
11:57 - 12:09 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
ES14.04 - Combining Immunotherapy and Anti-Angiogenic Agents
12:09 - 12:21 | Presenter: Enriqueta Felip
- Abstract
No abstract available for this presentation
-
+
ES14.05 - Combining Targeted Therapies With Immunotherapy
12:21 - 12:33 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
ES14.06 - Novel Immunotherapy Targets in NSCLC
12:33 - 12:45 | Presenter: Jie Wang
- Abstract
No abstract available for this presentation
-
+
MA05 - Lung Cancer Screening
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Screening and Early Detection
-
+
MA05.01 - Chair
11:45 - 11:45 | Presenter: Chong Kin Liam
- Abstract
No abstract available for this presentation
-
+
MA05.02 - Chair
11:45 - 11:45 | Presenter: Jacob Sands
- Abstract
No abstract available for this presentation
-
+
MA05.03 - Differential Frequency of Blood Immune Cells as Biomarkers for Risks Assessment in bioMILD Lung Cancer Screening Trial
11:45 - 11:50 | Presenter: Gabriella Sozzi
- Abstract
Loading... -
+
MA05.04 - Why are Lung Cancer Detection Rates Higher in the Manchester Lung Health Checks than in the National Lung Screening Trial?
11:50 - 11:55 | Presenter: Hilary A Robbins
- Abstract
Loading... -
+
MA05.05 - Low-Dose Chest Computed Tomographic Screening and Invasive Diagnosis of Pulmonary Nodules for Lung Cancer in Never-Smokers
11:55 - 12:00 | Presenter: Yeon Wook Kim
- Abstract
Loading... -
+
MA05.06 - Lung Cancer Screening – Cumulative Results from Five UK-Based Programmes
12:00 - 12:05 | Presenter: Haval Balata
- Abstract
Loading... -
+
MA05.07 - Discussant
12:05 - 12:10 | Presenter: Stephen Lam
- Abstract
No abstract available for this presentation
-
+
MA05.08 - Impact of Low-Dose CT Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis: Secondary Analysis of NLST
12:10 - 12:15 | Presenter: Chloe Chang Su
- Abstract
Loading... -
+
MA05.09 - Evaluation of Alternative Diagnostic Follow-Up Intervals for Lung-RADs Criteria on the Effectiveness of Lung Cancer Screening
12:15 - 12:20 | Presenter: Mehrad Bastani
- Abstract
Loading... -
+
MA05.10 - Performance of Draft 2020 USPSTF Lung-Cancer Screening Guidelines and Potential for use of Risk Models to Reduce Racial/Ethnic Disparities
12:20 - 12:25 | Presenter: Rebecca Landy
- Abstract
Loading... -
+
MA05.11 - Effect of Lowering the Starting Age for Lung Cancer Screening by Low-Dose Computed Tomography Among Women: A Harm-Benefit Analysis
12:25 - 12:30 | Presenter: Yihui Du
- Abstract
Loading... -
+
MA05.12 - Discussant
12:30 - 12:35 | Presenter: Hui Zhong Chai
- Abstract
No abstract available for this presentation
-
+
MA05.13 - Live Q&A
12:35 - 12:45
- Abstract
No abstract available for this presentation
-
+
OA08 - Putting the Patient at the Center: Holistic Patient Care
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Nursing and Allied Health Professionals
-
+
OA08.01 - Chair
11:45 - 11:45 | Presenter: Csaba Laszlo Degi
- Abstract
No abstract available for this presentation
-
+
OA08.02 - Chair
11:45 - 11:45 | Presenter: Yeur-Hur Lai
- Abstract
No abstract available for this presentation
-
+
OA08.03 - Joint Modeling of Stress and Survival in Patients with Advanced Non-Small Cell Lung Cancer
11:45 - 11:55 | Presenter: Nicole Andrea Arrato
- Abstract
Loading... -
+
OA08.04 - Providing Thoracic Prehabilitation during COVID-19: Review of a Virtual Model
11:55 - 12:05 | Presenter: Stephanie Wynne
- Abstract
Loading... -
+
OA08.05 - Illness Perception Profiles at Lung Cancer Diagnosis and Physical and Psychological Symptom Trajectories During Treatment
12:05 - 12:15 | Presenter: Thomas Robert Valentine
- Abstract
Loading... -
+
OA08.06 - How Complex is Fatigue? Occupational Therapy Playing a Lead Role in Fatigue Management
12:15 - 12:25 | Presenter: Pippa Labuc
- Abstract
Loading... -
+
OA08.07 - Discussant
12:25 - 12:35 | Presenter: Andreas Charalambous
- Abstract
No abstract available for this presentation
-
+
OA08.08 - Live Q&A
12:35 - 12:45
- Abstract
No abstract available for this presentation
-
+
IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies
- 13:00 - 14:00
- 1/30/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS11.01 - Introductions
13:00 - 13:00
- Abstract
No abstract available for this presentation
-
+
IS11.02 - Current Biomarker Landscape in NSCLC
13:00 - 13:20 | Presenter: Stephen Fox
- Abstract
No abstract available for this presentation
-
+
IS11.03 - Current Unmet Need in KRAS G12C-Mutated NSCLC
13:20 - 13:40 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS11.04 - Emerging Novel Targets for Lung Cancer
13:40 - 14:00 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
